Efficacy and safety of raltegravir for treatment of HIV for 5 years in the benchmrk studies: final results of two randomised, placebo-controlled trials

dc.creatorEron, Joseph J.
dc.creatorCooper, David A.
dc.creatorSteigbigel, Roy T.
dc.creatorClotet, Bonaventura
dc.creatorGatell, Jose M.
dc.creatorKumar, Princy N.
dc.creatorRockstroh, Jurgen K.
dc.creatorSchechter, Mauro
dc.creatorMarkowitz, Martin
dc.creatorYeni, Patrick
dc.creatorLoutfy, Mona R.
dc.creatorLazzarin, Adriano
dc.creatorLennox, Jeffrey L.
dc.creatorStrohmaier, Kim M.
dc.creatorWan, Hong
dc.creatorBarnard, Richard J. O.
dc.creatorNguyen, Bach-Yen T.
dc.creatorTeppler, Hedy
dc.date.accessioned2015-07-08T12:30:17Z
dc.date.accessioned2023-09-05T12:06:00Z
dc.date.available2015-07-08T12:30:17Z
dc.date.available2023-09-05T12:06:00Z
dc.date.created2015-07-08T12:30:17Z
dc.date.issued2013
dc.identifierERON, Joseph J. et al. Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials. Lancet Infectious Diseases, v.13, n.7, p.587–596, 2013.
dc.identifier1473-3099
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/11152
dc.identifier10.1016/S1473-3099(13)70093-8
dc.identifier1474-4457
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8649362
dc.languageeng
dc.publisherElsevier
dc.rightsrestricted access
dc.titleEfficacy and safety of raltegravir for treatment of HIV for 5 years in the benchmrk studies: final results of two randomised, placebo-controlled trials
dc.typeArticle


Este ítem pertenece a la siguiente institución